ADVANCED BIOMED INC (ADVB) Stock Income Statement
NASDAQ:ADVB - Nasdaq - US00752P1049 - Common Stock - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 2.54M | 3.07M | 2.37M | |||
| Research and Development | 880.20K | 1.38M | 1.62M | |||
| Selling, General, and Administrative Expenses | 1.66M | 1.69M | 754.80K | |||
| Operating Income | -2.54M | -3.07M | -2.37M | |||
| Interest Income/Expense | -241.20K | -490.20K | 200.00 | |||
| Other Income/Expense | 500.00 | -21.10K | -35.60K | |||
| Non Recurring Items | 0.00 | -150.20K | -1.62M | |||
| Income Before Taxes | -2.78M | -3.73M | -4.03M | |||
| Income Tax | N/A | N/A | 0.00 | |||
| Net Income | -2.78M | -3.73M | -4.03M | |||
| EBITDA | -2.14M | -2.71M | -2.25M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -0.13 | -0.17 | -0.19 | |||
| Statistics | ||||||
All data in USD